|
|
Office Locations:
|
1624 Market St, Suite 202, #96870
Denver, CO 80202
| | |
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
Related Sciences (RS) is a data-driven venture creation firm founded to discover new medicines for diseases with major unmet needs. RS assembles portfolios of promising therapeutic programs in breakthrough areas of biology led by distributed teams of field-leading scientists and clinicians from around the world. By integrating a range of data, scientific, drug discovery, and business model innovations, RS seeks to create medicines that have the greatest possible chances of working safely and effectively in patients within a virtual operating model that reduces costs, attrition risk, and geographic constraints, to maximize potential value creation. RS was founded by a team with deep expertise in life sciences company creation, investment strategy, and data science, and is backed by a luminary group of investors
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
